Skip to main content
Clinical Trials/NCT05149209
NCT05149209
Unknown
Not Applicable

One-Year Clinical Evaluation of a Fluoride, Calcium and Phosphate-Releasing New Bioactive Material Versus a Fluoride-Releasing Hybrid Restorative Material in Cervical Lesions: A Randomized Clinical Trial.

Cairo University1 site in 1 country30 target enrollmentDecember 15, 2021
ConditionsDental Caries

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dental Caries
Sponsor
Cairo University
Enrollment
30
Locations
1
Primary Endpoint
Marginal adaptation
Last Updated
4 years ago

Overview

Brief Summary

  • This study will be conducted to evaluate and compare the clinical performance of fluoride, calcium, and phosphate-releasing new bioactive material versus a fluoride-releasing hybrid restorative material in cervical lesions for one-year follow-up.
  • The clinical evaluation will be done using modified USPHS criteria at baseline,3,6,9 and 12 months.

Detailed Description

two groups of 30 patients will receive cervical restorations by using calcium and phosphate releasing hybrid restorative material (Activa™ Presto, Pulpdent®, USA), or a fluoride-releasing hybrid restorative material (Giomer, Shofu, Japan). Then these restorations will be evaluated at baseline, 3 months, 6 months, 9 months, and 12 months according to modified USPHS criteria in terms of marginal adaptation, Marginal discoloration, recurrent caries, retention, surface texture, and Post-operative sensitivity. * Examination and selection of all patients will be done according to inclusion and exclusion criteria. * A class v cavity will be prepared after local anesthesia has been given as required. Rubber dam isolation followed by the placement of restorative material according to the randomization sequence. * For the intervention: selective etching to enamel and universal bond agent to all the cavity will be applied first, followed by filling of the cavity with fluoride, calcium, and phosphate-releasing new bioactive material (Activa™ Presto, Pulpdent®, USA) using a 19-gauge applicator tip on the syringe and light-curing for 20 seconds between each 2mm layer. * For the control group: selective etching to enamel and universal bond agent to all the cavity will be applied first, followed by filling of the cavity with fluoride-releasing hybrid restorative material (Giomer, Shofu, Japan) and will be light polymerized using a light-emitting diode (LED) light-curing unit for 10 seconds between each 2mm layer.

Registry
clinicaltrials.gov
Start Date
December 15, 2021
End Date
December 30, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Nourhan Khaled Mohamed Samir

Resident at Conservative department

Cairo University

Eligibility Criteria

Inclusion Criteria

  • a)Inclusion Criteria of participants:
  • Male or female gender.
  • Only co-operative patients will be approved to participate in the trial.
  • Medically free adult patients.
  • The age range of the patients is 18-40 years. b)Inclusion Criteria of teeth:
  • Small to moderate cervical lesion.
  • Vital upper or lower teeth with no signs of irreversible pulpitis.
  • Caries extension shouldn't exceed mesiodistal width and inciso(occluso)-gingival length not exceed incisal (occlusal) one third.

Exclusion Criteria

  • a)Exclusion criteria of participants:
  • Allergic history concerning methacrylates
  • Pregnancy
  • Heavy smoking; xerostomia
  • Lack of compliance
  • Patients with disabilities.
  • Patients having systemic diseases or severe medically compromised.
  • Patients with severe bruxism, clenching, or temporomandibular joint disorders.
  • b)Exclusion criteria of the teeth:
  • Deep defects (close to the pulp, less than 1 mm distance).

Outcomes

Primary Outcomes

Marginal adaptation

Time Frame: one year

The restoration will be clinically assessed by visual inspection and explorer. Restorations will be given a score using modified USPHS criteria: Alfa: Closely adapted, no visible crevice Bravo: Visible crevice, the explorer will penetrate Charlie: Crevice in which dentin is exposed

Secondary Outcomes

  • Marginal Discoloration(one year)
  • postoperative sensitivity(one year)
  • Retention(one year)
  • Secondary caries(one year)
  • surface texture(one year)

Study Sites (1)

Loading locations...

Similar Trials